Slide 1: Teleflex Incorporated 2009 Financial Outlook Earnings Conference Call
Teleflex Incorporated 2009 Financial Outlook Earnings Conference Call Exhibit 99.2
Slide 2: Forward-Looking Statements/Additional Notes
Forward-Looking Statements/Additional Notes This presentation and our discussion contain forward-looking information and statements including, but not limited to, such matters as forecasted 2009 net sales, core revenue growth, operating margins, pension expense, earnings per share excluding special
Slide 3: Conference Call Logistics
Conference Call Logistics The release, accompanying slides, and replay webcast available online at www.teleflex.com (click on "Investors") Telephone replay available by dialing 888-286-8010 or for international calls, 617-801-6888, pass code number 95390184
Slide 4: Jeff Black, Chairman and Chief Executive Officer
Jeff Black Chairman and Chief Executive Officer
Slide 5: Financial Outlook
2009 Financial Outlook Net sales to exceed $2.4 billion Low to mid-single digit core revenue growth Foreign currency head wind in 2009 vs. 2008 Commercial group restructuring Overall adjusted operating margins in the mid-teens for the year Increased pension expense of ~ $11 million EPS excluding spe
Slide 6: Medical Segment Outlook
2009 Medical Segment Outlook Net sales exceeding $1.5 billion Low to mid-single digit core growth Core sales growth driven by: Continued penetration of anti-microbial critical care product lines Growth in regional anesthesia products Increased investment in N.A. sales & marketing International marke
Slide 7: Medical Segment Outlook
2009 Medical Segment Outlook FDA remediation spending of $5 - $7 million in 2009 vs. ~ $20 million in 2008 Assumes FDA restrictions clearance in 2nd half of 2009 Investment in internal RA/QA infrastructure R&D ~ 4% of net medical revenue Begin increase in R&D investment with reduction in FDA remedia
Slide 8: Aerospace Segment Outlook
2009 Aerospace Segment Outlook Net sales of $480 - $500 million Core revenues down ~ 2% Boeing 747-8 delay and reduction in 747-400 conversions Continued investment in new platforms for future growth Repair revenues flat with investment in repairs and mix continuing to positively impact margins Expa
Slide 9: Commercial Segment Outlook
2009 Commercial Segment Outlook Net sales of $410 - $425 million Low to mid-single digit core growth Rigging Services steady performance continues First half improvement in truck & rail auxiliary power units Increased interest in CNG conversion kits in South America Modern burner unit order Further
Slide 10: Kevin K. Gordon, Executive Vice President and Chief Financial Officer
Kevin K. Gordon Executive Vice President and Chief Financial Officer
Slide 11: Outlook Financial Goals
2009 Outlook Financial Goals $3.90 to $4.00 $3.90 to $4.00 $4.10 to $4.40 Over $2,400 1 1 = exclusive of tax payments of approximately $90 million related to gain on sale recorded in discontinued operations in 2007 $280 to $290
Slide 12: 2009 Outlook Assumptions
Pension expense increases ~ $11 million over 2008 Foreign currency headwind Effective tax rate: 24% to 25% Capex: $55 - $65 million Depreciation & Amortization expense: ~$120 million Repayment of debt & lower interest rates result in reduction in full- year interest expense Weighted average shares o
Slide 13: Arrow Integration Costs & Synergies
Annual pre-tax synergies of $18 - $20 million in 2009 Cumulative pre-tax synergies of $60 - $62 million achieved through 2009 Run-rate annual pre-tax synergies of $70 - $75 million by 2010 Integration costs of $14 - $16 million in 2009 $9 - $10 million restructuring expense $5 - $6 million operating
Slide 14: 2009 Outlook: EPS and Cash Flow from Operations
Low High Earnings per share from continuing operations including special charges $3.70 $4.10 Add-back special charges $0.40 $0.30 Earnings per share from continuing operations before special charges $4.10 $4.40 2009 Outlook Cash flow from operations $280 million $290 million
Slide 15: Jeff Black, Chairman and Chief Executive Officer
Jeff Black Chairman and Chief Executive Officer
Slide 16: Summary
Summary Diversified company largely defined by our medical technology business Low to mid-single digit core revenue growth EPS excluding special charges of $4.10 to $4.40 Complete Arrow integration with FDA clearance Synergies achieved in 2009 more than offset additional pension expense Cash flow fr
Slide 17: Question and Answer Session
Question and Answer Session Teleflex